$35.94
2.97% yesterday
Nasdaq, Nov 15, 10:00 pm CET
ISIN
US92337F1075
Symbol
VCYT
Sector
Industry

Veracyte Inc Target price 2024 - Analyst rating & recommendation

Veracyte Inc Classifications & Recommendation:

Buy
83%
Hold
8%
Sell
8%

Veracyte Inc Price Target

Target Price $42.80
Price $35.94
Potential
Number of Estimates 10
10 Analysts have issued a price target Veracyte Inc 2025 . The average Veracyte Inc target price is $42.80. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 12 analysts: 10 Analysts recommend Veracyte Inc to buy, 1 to hold and 1 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Veracyte Inc stock has an average upside potential 2025 of . Most analysts recommend the Veracyte Inc stock at Purchase.

Sales and Margin forecast 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Revenue Million $ 361.05 443.19
21.75% 22.75%
EBITDA Margin 4.19% 19.11%
248.64% 356.03%
Net Margin -21.89% 7.16%
64.27% 132.71%

12 Analysts have issued a sales forecast Veracyte Inc 2024 . The average Veracyte Inc sales estimate is

$443m
Unlock
. This is
4.20% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$447m 5.09%
Unlock
, the lowest is
$437m 2.70%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2023 $361m 21.75%
2024
$443m 22.75%
Unlock
2025
$489m 10.23%
Unlock
2026
$540m 10.50%
Unlock
2027
$588m 9.01%
Unlock
2028
$638m 8.40%
Unlock

11 Analysts have issued an Veracyte Inc EBITDA forecast 2024. The average Veracyte Inc EBITDA estimate is

$84.7m
Unlock
. This is
143.35% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$102m 193.82%
Unlock
, the lowest is
$21.0m 39.77%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2023 $15.1m 280.98%
2024
$84.7m 459.73%
Unlock
2025
$97.9m 15.56%
Unlock
2026
$116m 18.17%
Unlock
2027
$126m 9.20%
Unlock
2028
$140m 10.46%
Unlock

EBITDA Margin

2023 4.19% 248.64%
2024
19.11% 356.03%
Unlock
2025
20.03% 4.81%
Unlock
2026
21.42% 6.94%
Unlock
2027
21.46% 0.19%
Unlock
2028
21.87% 1.91%
Unlock

8 Veracyte Inc Analysts have issued a net profit forecast 2024. The average Veracyte Inc net profit estimate is

$31.8m
Unlock
. This is
392.66% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$85.8m 891.25%
Unlock
, the lowest is
$770k 107.10%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2023 $-79.0m 100.00%
2024
$31.8m 140.17%
Unlock
2025
$38.6m 21.67%
Unlock
2026
$50.9m 31.74%
Unlock
2027
$70.5m 38.57%
Unlock
2028
$91.4m 29.67%
Unlock

Net Margin

2023 -21.89% 64.27%
2024
7.16% 132.71%
Unlock
2025
7.91% 10.47%
Unlock
2026
9.43% 19.22%
Unlock
2027
11.98% 27.04%
Unlock
2028
14.33% 19.62%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Earnings Per Share $ -1.02 0.41
100.00% 140.20%
P/E 87.72
EV/Sales 5.71

8 Analysts have issued a Veracyte Inc forecast for earnings per share. The average Veracyte Inc <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

$0.41
Unlock
. This is
392.86% higher
Unlock
than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is
$1.11 892.86%
Unlock
, the lowest is
$0.01 107.14%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2023 $-1.02 100.00%
2024
$0.41 140.20%
Unlock
2025
$0.50 21.95%
Unlock
2026
$0.66 32.00%
Unlock
2027
$0.91 37.88%
Unlock
2028
$1.18 29.67%
Unlock

P/E ratio

Current -248.72 671.22%
2024
87.72 135.27%
Unlock
2025
72.09 17.82%
Unlock
2026
54.73 24.08%
Unlock
2027
39.49 27.85%
Unlock
2028
30.46 22.87%
Unlock

Based on analysts' sales estimates for 2024, the Veracyte Inc stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 5.95 42.34%
2024
5.71 4.02%
Unlock
2025
5.18 9.28%
Unlock
2026
4.69 9.50%
Unlock
2027
4.30 8.26%
Unlock
2028
3.97 7.75%
Unlock

P/S ratio

Current 6.55 38.59%
2024
6.28 4.03%
Unlock
2025
5.70 9.28%
Unlock
2026
5.16 9.50%
Unlock
2027
4.73 8.26%
Unlock
2028
4.37 7.75%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today